Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMS | TSHA | ASMB | ||
| Company | Adamas Pharma | Taysha Gene Therapies Inc | Assembly Biosciences | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.24 | 2.24 | 12.60 | ||
| High | 8.25 | 2.29 | 12.60 | ||
| Low | 8.18 | 2.14 | 11.52 | ||
| Last | 8.22 | 2.15 | 12.15 | ||
| Change | +0.06 | -0.01 | -1.20 | ||
| % Change | +0.74% | -0.46% | -8.99% | ||
| Volume | 3,151,400 | 810,043 | 38,175 | ||
| 20-Day Average Volume | 834,440 | 4,528,282 | 19,579 | ||
| Previous Close | 8.16 | 2.16 | 13.35 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.16 | 3.12 | 14.76 | ||
| 20-Day Raw Stochastic | 86.36% | 12.85% | 12.78% | ||
| 20-Day Relative Strength | 73.46% | 38.45% | 35.51% | ||
| Weighted Alpha | +22.54 | -1.38 | -13.19 | ||
| Today's Opinion | 100% Buy | 8% Buy | 24% Buy | ||
| Previous Opinion | 96% Buy | 8% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.86% since 11/16/21 | +5.39% since 06/26/24 | -15.03% since 06/26/24 | ||
| Low | 8.15 on 11/17/21 | 2.04 on 06/27/24 | 11.52 on 07/03/24 | ||
| High | 8.25 on 11/23/21 | 2.40 on 07/01/24 | 14.75 on 06/28/24 | ||
| 1-Month | |||||
| %Chg | +2.62% since 10/22/21 | -40.61% since 06/03/24 | -18.73% since 06/03/24 | ||
| Low | 8.00 on 10/25/21 | 1.83 on 06/26/24 | 11.52 on 07/03/24 | ||
| High | 8.25 on 11/23/21 | 4.32 on 06/13/24 | 16.45 on 06/06/24 | ||
| 3-Month | |||||
| %Chg | +77.54% since 08/23/21 | -20.96% since 04/03/24 | -11.89% since 04/03/24 | ||
| Low | 4.41 on 08/27/21 | 1.83 on 06/26/24 | 11.52 on 07/03/24 | ||
| High | 8.25 on 11/23/21 | 4.32 on 06/13/24 | 16.45 on 06/06/24 | ||
| 6-Month | |||||
| %Chg | +57.47% since 05/21/21 | +27.22% since 01/03/24 | +24.75% since 01/03/24 | ||
| Low | 4.02 on 08/16/21 | 1.38 on 01/19/24 | 9.12 on 01/17/24 | ||
| High | 8.25 on 11/23/21 | 4.32 on 06/13/24 | 16.45 on 06/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 376,369 | 403,959 | 73,602 | ||
| Shares Outstanding, K | 45,787 | 187,018 | 5,513 | ||
| Annual Sales | 74,460,000 | 15,450,000 | 7,160,000 | ||
| Annual Net Income | -57,400,000 | -111,570,000 | -61,230,000 | ||
| Last Quarter Sales | 25,900,000 | 3,410,000 | 5,790,000 | ||
| Last Quarter Net Income | -19,520,000 | -24,060,000 | -9,080,000 | ||
| 60-Month Beta | 2.82 | 0.42 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/10/21 | -0.10 on 05/14/24 | -1.66 on 05/08/24 | ||
| Latest Earnings Date | 11/11/21 | 08/12/24 | 08/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||